catechol has been researched along with thromboxane a2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, CP; Chang, HH; Chang, MC; Cheng, RH; Jeng, JH; Lin, BR; Wang, TM; Yeh, CY; Yeung, SY | 1 |
1 other study(ies) available for catechol and thromboxane a2
Article | Year |
---|---|
Antiplatelet effect of catechol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arachidonic Acid; Blood Platelets; Catechols; Cyclooxygenase Inhibitors; Humans; MAP Kinase Signaling System; Neutrophils; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prostaglandin-Endoperoxide Synthases; Rabbits; Reactive Oxygen Species; Thromboxane A2 | 2014 |